| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Emanuele Nicastri | Q28743725 |
| Massimo Andreoni | Q39747196 | ||
| Antonio Chiesi | Q42730250 | ||
| Stefano Vella | Q56451079 | ||
| Loredana Sarmati | Q56863277 | ||
| P2093 | author name string | Angela Corpolongo | |
| Pasquale Narciso | |||
| Claudio Angeletti | |||
| Sebastiano Leone | |||
| Lucia Palmisano | |||
| Andrea Geraci | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 724-732 | |
| P577 | publication date | 2007-08-21 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review | |
| P478 | volume | 60 |
| Q36788594 | Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high-risk sexual behavior, including men who have sex with men, in coastal Kenya |
| Q36419116 | Adult HIV care resources, management practices and patient characteristics in the Phase 1 IeDEA Central Africa cohort |
| Q36522288 | Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy |
| Q35074791 | Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. |
| Q28743488 | Asking the right questions: developing evidence-based strategies for treating HIV in women and children |
| Q34275856 | Association between human immunodeficiency virus infection and stiffness of the common carotid artery |
| Q26768632 | Barriers to a cure for HIV in women |
| Q35867586 | Beyond the Brain: The Role of Brain-Derived Neurotrophic Factor in Viroimmune Responses to Antiretroviral Therapy among People Living with HIV with and without Alcohol Use. |
| Q57180790 | British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 |
| Q34730855 | CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy |
| Q37212049 | Caring for women living with HIV: gaps in the evidence. |
| Q36661756 | Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. |
| Q43789646 | Determinants of adherence in a cohort of Belgian HIV patients: a pilot study |
| Q36157703 | Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial |
| Q43438000 | Does the success of HIV treatment depend on gender? |
| Q34119037 | Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis |
| Q47571783 | Effect of Probiotic Supplementation on CD4 Cell Count in HIV-Infected Patients: A Systematic Review and Meta-analysis |
| Q38440869 | Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy |
| Q40050198 | Envisioning Women-Centered HIV Care: Perspectives from Women Living with HIV in Canada |
| Q37727385 | Epidemiological surveillance of the HIV/AIDS complex through the analysis of trends in the incidence of Kaposi's sarcoma in Cali, Colombia |
| Q34754376 | Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study |
| Q37937036 | Gender differences in HIV manifestations at presentation to care and continuity of care among HIV-infected persons in Taiwan |
| Q38872693 | Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda |
| Q28538221 | Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study |
| Q33873986 | Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients |
| Q34170487 | Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa |
| Q38418210 | Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study |
| Q28541096 | Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010) |
| Q34272202 | Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda |
| Q91862873 | HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial |
| Q47285024 | Health-related quality of life and coping strategies among people living with HIV: the moderating role of gender |
| Q40253160 | Health-related quality-of-life and receipt of women-centered HIV care among women living with HIV in Canada |
| Q91997307 | Hiring, training, and supporting Peer Research Associates: Operationalizing community-based research principles within epidemiological studies by, with, and for women living with HIV |
| Q36298353 | How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study |
| Q37341001 | How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? |
| Q34517582 | Immigrant women living with HIV in Spain: a qualitative approach to encourage medical follow-up |
| Q34768318 | Individual and contextual factors of influence on adherence to antiretrovirals among people attending public clinics in Rio de Janeiro, Brazil |
| Q36127917 | Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care |
| Q34731031 | Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality |
| Q37410986 | Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIV. |
| Q51858935 | No differences in quality of life between men and women undergoing HIV antiretroviral treatment. Impact of demographic, clinical and psychosocial factors. |
| Q33951598 | Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study |
| Q40052482 | Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study |
| Q39550582 | Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia |
| Q36303839 | Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men |
| Q37712960 | Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women |
| Q39372748 | Response to combined antiretroviral therapy according to gender and origin in a cohort of naïve HIV-infected patients: GESIDA-5808 study |
| Q35896106 | Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study |
| Q35930699 | Sex and Racial/Ethnic Differences in Premature Mortality Due to HIV: Florida, 2000-2009. |
| Q33566578 | Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review |
| Q96219403 | Sex differences in HIV treatment outcomes and adherence by exposure groups among adults in Guangdong, China: A retrospective observational cohort study |
| Q34870233 | Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review |
| Q58104425 | Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation |
| Q34664004 | Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial |
| Q36093602 | Temporal trends in the discontinuation of first-line antiretroviral therapy |
| Q37252714 | The X-files in immunity: sex-based differences predispose immune responses |
| Q33893572 | The association between HIV (treatment), pregnancy serum lipid concentrations and pregnancy outcomes: a systematic review |
| Q37407528 | The impact of gender and income on survival and retention in a South African antiretroviral therapy programme |
| Q37321334 | The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome |
| Q37416422 | The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review |
| Q92510777 | Trajectories of Health-Related Quality of Life and Perceived Social Support Among People Living With HIV Undergoing Antiretroviral Treatment: Does Gender Matter? |
| Q26851185 | Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS |
| Q37301168 | X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women |
Search more.